Third Quarter Financial Results for the Fiscal Year Ending March 31, 2010
January 28, 2010
Exchange where listed: TSE

Name of listed company: TERUMO CORPORATION(URL http://www.terumo.com/): 4543: Akira Takahashi, President: Shouji Hatano, Executive Officer, General Manager, Corporate Communication Dept.
: +81 / 3-3217 -6550

Company code number
Representative:
Please address all communications toPhone

1. Consolidated financial highlights for the interim period ended December 2009
(From April 1, 2009 to December 31, 2009)(1) Consolidated financial results
Net sales

Operating incomeOrdinary income

Net income(Millions of yen)%

(Millions of yen)%

(Millions of yen)%

(Millions of yen)

238,897
231,526

3.2－

49,98945,5279.8－

50,36942,72117.9－

31,85828,745

Nine months ended December,2009
Nine months ended December,2008

%

10.8
－

Net income per share, fully
diluted

Net income per share(Yen)

(Yen)

－
167.77
Nine months ended December,2009
148.95－
Nine months ended December,2008(Note) Percentage represent increase (decrease) from the corresponding period in the prior fiscal year.
The amounts shown above ignore values of less than a million yen.
(2) Consolidated financial position
Total assets

Capital asset ratio

Net assets

Net assets per share(Millions of yen)

(Millions of yen)

%

(Yen)

405,284
379,064

309,478
278,16676.3
73.4

1,628.93
1,464.27

December 31, 2009
March 31, 2009

(Note) Shareholders' equity : December 31, 2009: 309,327 million yen, March 31, 2009: 278,062 million yen.
The amounts shown above ignore values of less than a million yen.

2. Dividends

1st quarter

Fiscal year ended March 31,2009Fiscal year ending March 31,2010
Fiscal year ending March 31,2010 (forecast)

Dividends per share
2nd quarter 3rd quarter 4th quarter

total(Yen)

(Yen)

(Yen)

(Yen)

(Yen)

－－

16.00
16.00

－－

16.00

32.00

16.00

32.00

(Note) Revise of dividends forecast : None

3. Consolidated forecast for the year ending March 2010 (From April 1, 2009 to March 31, 2010)
Operating income

Net sales

Fiscal year ending March, 2010

Net income
per share

Net income

Ordinary income(Millions of yen)%

(Millions of yen)%

(Millions of yen)%

(Millions of yen)%

315,000

4.0

63,00016.6

61,00016.0

40,0008.5(Yen)210.64

1. Forecast for fiscal year ending March, 2010 which was announced on Oct 29, 2009 has not been revised.
2. Among the information that Terumo discloses, forecasts of financial performance on future projections contain potential risks and uncertainty since these areforecasts on projections made by Terumo based on limited information available at the moment of disclosure. Accordingly, it should be noted that actual
results may differ from those forecasts on projections due to various factors. Factors affecting to actual results include, but are not limited to, changes in
economic conditions surrounding Terumo, fluctuations of foreign exchange rates, and state of competition.

14. Consolidated Financial Statements(1) Consolidated Balance Sheets(Millions of yen)
As of December 31,2009
Amount(Assets)
I Current assets

215,174%
53.1%

As of March 31, 2009
Amount
193,658

Cash and deposits

73,21857,073

Notes and accounts receivable-trade76,436

66,865Merchandise and finished goods

32,701

33,272Work in process

5,817

6,373

Raw material and supplies

15,492

14,945

Deferred tax assets7,617

9,687

Other

4,638

6,173

Allowance for doubtful accounts

(747)

(733)

%
51.1%

II Noncurrent assets

190,10946.9%

185,406

48.9%

1. Property, plant and equipment

111,44427.5%

111,064

29.3%

Buildings and structures

43,09941,545

Machinery, equipment and vehicles

30,19333,067

Land

20,27020,303627

548

Construction in progress

10,586

8,584

Other

6,668

7,015

Lease assets

2. Intangible assets

30,338

7.5%

Goodwill

23,354

26,823

Other

6,984

5,923

3. Investments and other assets

48,326

Investment securities

36,22023,686

Deferred tax assets

6,262

11,528

Other

5,842

6,378

Total Assets

405,284

2

11.9%

32,747100.0%

41,593379,064

8.6%

11.0%

100.0%

(Millions of yen)
As of December 31,2009
Amount(Liabilities)
I Current liabilities

87,679%21.6%

As of March 31, 2009
Amount
93,700Notes and accounts payable-trade26,14427,812

Short-term loans payable

20,00025,190186

161

Income taxes payable

7,583

6,022

Deferred tax liabilities

342

173

Provision for bonuses

2,473

4,758

142

172

Notes and accounts payable - facilities

4,694

5,605

Other

26,11323,804

Lease obligations

Provision for directors' bonuses

II Noncurrent liabilities

8,127

Lease obligations

460

409

Deferred tax liabilities

24103

Provision for directors' retirement benefits

4,251
658

3,691
659

Other

2,731

2,331

Provision for retirement benefits

Total Liabilities(Net Assets)
I Shareholders' Equity

2.0%

7,196%
24.7%

1.9%

95,80623.6%

100,89726.6%

328,77681.1%

303,005

80.0%

Capital stock

38,716

38,716

Capital surplus

59,03059,030Retained earnings

307,840

282,058

Treasury stock(76,811)(76,800)

II Valuation and translation adjustments(19,448)

Valuation difference on available-for-salesecurities

2,430(5,118)(21,878)150

0.1%(19,823)104

0.0%

309,47876.4%

278,16673.4%

405,284

100.0%

379,064100.0%

Foreign currency translation adjustment

III Minority interests
Total Net assets
Total Liabilities and Net Assets

3(4.8%)(24,942)(6.6%)

(2) Consolidated Statements of Income(Millions of yen)

Nine months ended
December 31, 2008
AmountI Net sales
II Cost of sales
Gross profit
Selling, general andIII administrative expenses

Operating income
IV Non-operating income%

Nine months ended
December 31, 2009
Amount%ChangesAmount%231,526

100.0%

238,897

100.0%

7,371

3.2%

108,05446.7%

112,835

47.2%

4,780

4.4%

123,47153.3%

126,062

52.8%

2,591

2.1%

77,944

33.6%

76,07331.9%(1,871)(2.4%)

45,52719.7%

49,989

20.9%

4,462

9.8%

(1,049)(44.6%)(4,235)(82.1%)

7,648

17.9%

(95)

(98.2%)

Interest income

1,027

323

(704)

Dividends income

418

262

(156)

Royalty income

1021119Equity in earnings of affiliates

6172

11

Other

740

2,350

1.0%

532

1,301

0.6%

(208)

V Non-operating expenses
Interest expenses

286

118(167)

Sales discounts

413

438

25

Foreign exchange losses

3,274

198

(3,075)

Loss on disposal of inventories

243

66

Other

939

5,157

2.2%

42,721

18.5%

1780

970.0%

129
33

162

0.1%

42,65518.4%

13,882

6.0%

Minority interests in income

28

Net income for the period

28,745

Ordinary income
VI Extraordinary income
Gain on sales of noncurrent assets
Gain on sales of investment securities

98

(176)
921

0.4%

50,369

21.1%

(840)

1－

10.0%

(15)
(80)

64－

64

0.0%

(65)
(33)

50,30621.1%

18,411

7.8%

0.0%

36

0.0%

8

28.5%

12.4%

31,858

13.3%

3,113

10.8%

VII Extraordinary loss
Loss on disposal of noncurrent assets
Loss on appraisal of securities

Income before income taxes
Income taxes-current

12,547

Income taxes-deferred

1,334

16,161

4

2,250

(98)

(60.5%)

7,651

17.9%

4,529

32.6%

3,614
915

(3) Consolidated Statements of Cash Flows

I(Millions of yen)Nine months ended

Nine months ended

December 31, 2008

December 31, 2009

AmountAmountNet cash provided by (used in) operating activities
Income before income taxes
Depreciation and amortization
Amortization of goodwill
Equity in (earnings) losses of affiliates
Increase (decrease) in provision for retirement benefits
Increase(decrease) in reserve for retirement benefits for directors
and corporate auditors
Increase (decrease) in allowance for doubtful accounts
Increase (decrease) in provision for directors' bonuses

42,655
13,107
1,534(61)(263)

50,306
13,263
1,269(72)568(68)(1)32(47)

17(30)

Interest and dividends income
Interest expenses
Foreign exchange losses (gains)
Loss (gain) on disposal of noncurrent assets
Loss (gain) on sales of noncurrent assets
Loss (gain) on sales of short-term and long term investment
securities(1,446)286
1,194
129(17)

(585)
118
286
64(1)

(80)

－

Loss on appraisal of securities
Decrease (increase) in notes and accounts receivable-trade
Decrease (increase) in inventories
Increase (decrease) in notes and accounts payable-trade
Other, net

33(4,680)(7,085)
1,816(7,918)
39,118
1,622(338)(28,769)
11,633－(9,856)50(1,698)
3,805
57,505791(129)(14,842)
43,325Sub-totalInterest and dividends income received
Interest expenses paid
Income taxes paid

Net cash provided by (used in) operating activities
II Net cash provided by (used in) investment activities
Payments into time deposits
Proceeds from withdrawal of time deposits
Purchase of property, plant and equipment
Proceeds from sales of property, plant and equipment
Purchase of intangible assets
Purchase of investment securities
Capital gain from redemption of marketable securities
Proceeds from sales of investment securities
Purchase of investments in subsidiaries resulting in change in scopeof consolidation(3,438)(15,256)

2,983(11,614)
17(820)
(32)
－
580

9,646
(14,543)8(809)(108)
100－(3,286)－

Net cash provided by (used in) investment activities(15,612)(20,962)(4,990)(18,006)－(6,593)(29,589)(4,022)(5,190)(11)(148)(6,076)(11,426)(262)(37,591)
85,37747,786

10,67455,06765,741

III Net cash provided by (used in) financing activities
Net increase (decrease) in short-term loans payable
Purchase of treasury stock
Repayments of finance lease obligations
Cash dividends paid

Net cash provided by (used in) financing activities
IV Effect of exchange rate change on cash and cash equivalents
V Net increase (decrease) in cash and cash equivalents
VI Cash and Cash Equivalents at Beginning of Period
VII Cash and Cash Equivalents at End of Period

55. Segment Information(1) Business Segments(Millions of yen)
Nine months ended
December 31, 2008
AmountSales
General hospital products
Cardiac & Vascular products
Blood transfusion products
Consumer Health Care products
Corporate expenses
Total

113,048
96,246
18,215
4,015－
231,526

Operatingincome24,967
26,6352,809
243(9,129)45,527(Millions of yen)
Nine months ended
December 31, 2009
AmountSales
General hospital products
Cardiac & Vascular products
Blood transfusion products
Consumer Health Care products
Corporate expenses
Total

114,669
101,164
17,921
5,142－
238,897

Operatingincome27,207
29,156
2,660
575(9,610)49,989(Note) Main products belonging to each product segment

Product segments

Main products

General hospital products
Disposable medical devices
and Medical electronics

Syringes, Needles, Solution sets, I.V.catheters, Blood collection tubes, Electronic
medical equipments, etc.

Pharmaceuticals

I.V.solutions, Prefilled syringes, Nutritious foods, etc.

CAPD products

Dialysis solutions, etc.

Diabetes care products

Blood glucose monitors, etc.

Home parenteral nutrition and oxygen

Home parenteral nutrition, Home oxygen systems, etc.

Cardiac and Vascular productsInterventional systems

Angiographic catheters, PTCA catheters, Coronary stents, Neuro Interventional coils,etc.

Cardiovascular systems

Oxygenarators, Roller pumps, Blood tubing sets, etc.

Vascular grafts

Artificial vascular grafts

Blood transfusion products

Blood bags, Automated blood processing products, etc.

Consumer health care products

Digital Thermometers, Blood pressure monitors, Blood glucose monitors (OTC), etc.

6(2) Geographic segments(Millions of yen)
Nine months ended
December 31, 2008
AmountSales to customer

JapanEurope
Americas
Asia and others
Corporate expenses / eliminations
Total

124,205
42,864
42,12722,328－
231,526

Internal sales

36,473
2,989
4,485
11,573(55,521)－Operating
income41,743
5,638
1,736
5,897(9,488)
45,527(Millions of yen)

Nine months ended
December 31, 2009
AmountSales to customer

JapanEurope
Americas
Asia and others
Corporate expenses / eliminations
Total

133,167
41,365
42,104
22,260－238,897

Internal sales

36,288
3,163
4,108
11,513(55,074)－(3) Sales results by regions(Millions of yen)
Nine months ended
December 31, 2008
Amount%Japan
124,158
53.6%
Europe42,864
18.5%
Americas42,127
18.2%
Asia and others
22,375
9.7%
Total
231,526
100.0%(Note) Sales in 'Asia and others' includes direct sales from Japan.
(Millions of yen)
Nine months ended
December 31, 2009
Amount%Japan
133,134
55.7%
Europe41,365
17.3%
Americas42,104
17.6%
Asia and others
22,294
9.4%
Total
238,897
100.0%(Note) Sales in 'Asia and others' includes direct sales from Japan.

7

Operatingincome45,527
5,655
2,808
6,666
(10,668)
49,989